Clinical Trial Update: Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating GM-CSF in combination with ketoconazole and mitoxantrone for progressive prostate cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Ketoconazole (Ketoconazole)
• Leukine (sargramostim)
• Novantrone (mitoxantrone)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Prostatic Neoplasms | Phase 2 | Status: TERMINATED